Illustrative image – not actual.Singapore-based pharmaceuticals company Invida is planning to acquire New Delhi's Shalaks Pharmaceuticals.
The company will acquire Shalaks Pharma for $25 million (approx Rs 125 crore). Shalaks manufactures and markets prescription and OTC skincare products like sunscreen lotions, skin rash creams, soaps and cosmetics.
The company will acquire Shalaks Pharma for $25 million (approx Rs 125 crore). Shalaks manufactures and markets prescription and OTC skincare products like sunscreen lotions, skin rash creams, soaps and cosmetics.
